Researcher.Life Logo

Antimicrobial Agents and Chemotherapy : Impact Factor & More

eISSN: 1098-6596pISSN: 0066-4804

Aims and Scope of Antimicrobial Agents and Chemotherapy

Antimicrobial Agents and Chemotherapy is a peer-reviewed scientific journal published by the American Society for Microbiology. It covers antimicrobial, antiviral, antifungal, and antiparasitic agents and chemotherapy. The editor-in-chief is Cesar A. Arias (University of Texas Health Science Center at Houston). It was established in 1972 by Gladys Lounsbury Hobby. Less

Key Metrics

CiteScore
9.3
Impact Factor
< 5
Scite Index
0.89 5-Year SI
SJR
Q1Pharmacology
SNIP
1.4
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Antimicrobial Agents and Chemotherapy

Antimicrobial Agents and Chemotherapy Journal Specifications

Overview
Publisher AMER SOC MICROBIOLOGY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1953
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Antimicrobial Agents and Chemotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Antimicrobial Agents and Chemotherapy

Targeting reactivated toxoplasmosis: therapeutic efficacy of the green-synthesized copper nanoparticles combined with pyrimethamine.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Achieving therapeutic antibiotic levels during intermittent dosing of meropenem and piperacillin-tazobactam in critically ill children: the ATACC study.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Solving the degradation problem of continuous ceftazidime infusions-the Cooltaz study.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Pralatrexate is a potent pan-serotype human adenovirus inhibitor through suppression of dihydrofolate reductase.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Targeting reactivated toxoplasmosis: therapeutic efficacy of the green-synthesized copper nanoparticles combined with pyrimethamine.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Sulbactam-durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia-associated Fitz-Hugh-Curtis syndrome.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Achieving therapeutic antibiotic levels during intermittent dosing of meropenem and piperacillin-tazobactam in critically ill children: the ATACC study.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Solving the degradation problem of continuous ceftazidime infusions-the Cooltaz study.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy
Pralatrexate is a potent pan-serotype human adenovirus inhibitor through suppression of dihydrofolate reductase.
  • 1 Jul 2026
  • Antimicrobial agents and chemotherapy

FAQs on Antimicrobial Agents and Chemotherapy